Osaic Holdings
MRVI icon

Osaic Holdings’s Maravai LifeSciences MRVI Stock Holding History

Osaic Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
1,703
+564
+50% +$2.44K ﹤0.01% 6583
2026
Q1 		$3.22K Sell
1,139
-34
-3% -$115 ﹤0.01% 6873
2025
Q4 		$3.81K Sell
1,173
-279
-19% -$939 ﹤0.01% 6844
2025
Q3 		$3.74K Sell
1,452
-4,130
-74% -$10.5K ﹤0.01% 6903
2025
Q2 		$13.4K Buy
5,582
+4,558
+445% +$9.58K ﹤0.01% 5978
2025
Q1 		$2.26K Sell
1,024
-6,033
-85% -$23.8K ﹤0.01% 6543
2024
Q4 		$38.5K Buy
7,057
+2,735
+63% +$17.6K ﹤0.01% 4890
2024
Q3 		$35.9K Buy
4,322
+347
+9% +$3K ﹤0.01% 4975
2024
Q2 		$28.5K Buy
3,975
+119
+3% +$1.03K ﹤0.01% 5092
2024
Q1 		$33.4K Buy
3,856
+829
+27% +$5.61K ﹤0.01% 5017
2023
Q4 		$19.8K Sell
3,027
-2,875
-49% -$18.6K ﹤0.01% 5503
2023
Q3 		$59K Buy
5,902
+2,558
+76% +$28.1K ﹤0.01% 4875
2023
Q2 		$41.6K Sell
3,344
-1,374
-29% -$18.5K ﹤0.01% 5058
2023
Q1 		$66.1K Buy
4,718
+524
+12% +$7.53K ﹤0.01% 4771
2022
Q4 		$60.7K Buy
4,194
+678
+19% +$10.7K ﹤0.01% 4792
2022
Q3 		$90K Buy
3,516
+425
+14% +$10.7K ﹤0.01% 4468
2022
Q2 		$88K Sell
3,091
-23,195
-88% -$735K ﹤0.01% 4525
2022
Q1 		$928K Buy
26,286
+23,643
+895% +$793K ﹤0.01% 2646
2021
Q4 		$111K Buy
2,643
+22
+0.8% +$891 ﹤0.01% 4508
2021
Q3 		$128K Sell
2,621
-29,671
-92% -$1.45M ﹤0.01% 4304
2021
Q2 		$1.35M Buy
32,292
+28,302
+709% +$1.1M ﹤0.01% 2073
2021
Q1 		$142K Buy
3,990
+2,097
+111% +$69.5K ﹤0.01% 4058
2020
Q4 		$53K Buy
+1,893
New +$52.7K ﹤0.01% 4518

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Osaic Holdings's MRVI Position: Q2 2026 in Review

Osaic Holdings increased its Maravai LifeSciences (MRVI) stake by 50% in Q2 2026, buying an estimated $2.44K and bringing the position to 1,703 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6583.

Osaic Holdings first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.35M in Q2 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Osaic Holdings held 1,703 shares of Maravai LifeSciences worth $10.6K as of Q2 2026.
  • Osaic Holdings bought 564 Maravai LifeSciences shares in Q2 2026, an estimated $2.44K.
  • Maravai LifeSciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6583 holding.
  • Osaic Holdings first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Maravai LifeSciences position peaked at $1.35M in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.